About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Chicago | 715 Studies

Clinical Trials Breast CancerChicago

Breast Cancer Clinical Trials in Chicago

Find 715 clinical trials for breast cancer near Chicago, Illinois. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 501-520 of 715 trials

TerminatedWindow of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFRPrimary Objective: To determine if dasatinib, an inhibitor of the Src family kinases, can prevent the nuclear translocation of the epidermal growth factor receptor (EGFR) in…NCT02720185·Chicago, Illinois and 1 other WithdrawnMagnetic Resonance Thermal Image Guided Laser Interstitial Thermal Therapy in Treating Patients With Breast CancerThis pilot clinical trial studies magnetic resonance thermal image guided laser interstitial thermal therapy in treating patients with breast cancer.NCT01791998·Chicago, Illinois TerminatedStudy of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsThis study is an open-label, international, multi-center, Phase 2 study in adult patients with recurrent, locally-advanced or metastatic solid tumors, which harbor the NRG1 gene…NCT04383210·Birmingham, Alabama and 41 others

Breast Cancer Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingSaruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast CancerThe primary objective of the study is to measure efficacy of saruparib (AZD5305) plus camizestrant compared with physician's choice CDK4/6i plus ET in patients with BRCA1, BRCA2…NCT06380751·Gilbert, Arizona and 305 others

CompletedBupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic CancerThis phase II randomized trial studies how well bupropion hydrochloride works in improving sexual desire in women with breast or gynecological cancer.NCT03180294·Anaheim, California and 361 others

RecruitingPhase IIIb Study of Ribociclib + ET in Early Breast CancerThe purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant…NCT05827081·Birmingham, Alabama and 228 others

CompletedAssessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast SurgeryThis phase II trial studies how well biopsy of breast after chemotherapy works in predicting pathologic response in patients with stage II-IIIA breast cancer undergoing breast…NCT03188393·Birmingham, Alabama and 380 others

CompletedEfficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer RecurrencePurpose of this trial: 1. To assess the efficacy and safety of NeuVax™ administered with adjuvant Leukine® (sargramostim, GM-CSF).NCT01479244·Bessemer, Alabama and 196 others

TerminatedPhase II Study of Carboplatin and Bevacizumab (Avastin) for ER Neg, PR Neg, and HER2/Neu Neg Metastatic Breast CancerThe purpose of this study is to determine the progression free survival (PFS) of metastatic ER, PR and HER2/neu negative breast cancers to the combination of carboplatin and…NCT00517361·Chicago, Illinois and 1 other

Active not recruitingRegional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast CancerThe purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation…NCT03488693·Fairbanks, Alaska and 484 others

CompletedEverolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or AnastrozoleThere are no treatments specifically approved after recurrence or progression on a non steroidal aromatase inhibitors (NSAI).NCT00863655·Chandler, Arizona and 199 others

RecruitingAVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid TumorsThis is a first-in-human (FIH), Phase 1 open-label, multicenter dose escalation study investigating AVA6103 monotherapy administered intravenously in patients with locally…NCT07454642·Scottsdale, Arizona and 6 others

CompletedPRospective Study Of MammaPrint in Patients With an Intermediate Recurrence ScoreThis is a prospective study that will assess the impact of MammaPrint on chemotherapy + endocrine versus endocrine alone treatment decisions in patients with an Oncotype…NCT01617954·Phoenix, Arizona and 52 others

CompletedA Study Of PF-06647020 For Adult Patients With Advanced Solid TumorsTo assess the safety and tolerability at increasing dose levels of PF-06647020 in patients with advanced solid tumors in order to determine the maximum tolerated dose and select…NCT02222922·Birmingham, Alabama and 16 others

CompletedA Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast CancerTo demonstrate whether addition of MM-121 to paclitaxel is more effective than treatment with paclitaxel alone, when administered as part of the neoadjuvant treatment in Her2…NCT01421472·Birmingham, Alabama and 37 others

TerminatedIpilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast CancerThe purpose of this research study is to look at the efficacy (the effect on tumor) and the safety (the effect on body) of the study drugs when given as a combination in patients…NCT02892734·Chicago, Illinois

CompletedA Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid TumoursThis is a Phase I, open-label, multi-centre, drug combination study of double and triple combination oral selumetinib (AZD6244 Hyd-sulfate) plus intravenous (IV) MEDI4736 and oral…NCT02586987·Chicago, Illinois and 5 others

UnknownTavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBCThis is a Phase 2, Multi-Cohort, Open-Label, Multi-Center Study.NCT03567720·Tucson, Arizona and 13 others

CompletedDigital Mammography Screening Trial (ACRIN6652)RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for cancer.NCT00008346·Los Angeles, California and 31 others

TerminatedTucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMDA phase 2 non-randomized study to assess the safety and efficacy of the combination of tucatinib and trastuzumab with capecitabine for the treatment of leptomeningeal metastases…NCT03501979·Birmingham, Alabama and 8 others

PreviousPage 26 of 36Next

Other Conditions in Chicago

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma